APOE ε4 significantly increases risk for DLB and decreases survival.
Pathogenic missense mutations and risk variants in GBA, PSEN1 and APP are common in DLB.
Genetic defects place DLB along a spectrum between Parkinson disease and Alzheimer dementia.